Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting.
Giovanni PerriconeChristophe DuvouxMarina BerenguerPaolo Angelo CortesiCarmen Vinaixa-AunésRita FacchettiChiara MazzarelliSusanne-Rasoul RockenschaubSilvia MartiniCristina MorelliSara MonicoRiccardo VolpesGeorges-Philippe PageauxStefano FagiuoliLuca Saverio Bellinull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
Antiviral therapy allows for a long-term improvement of liver function and the delisting of one-third of treated patients with risk of liver-related complications after delisting being very low.